# Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin

> **NCT00213122** · PHASE3 · COMPLETED · sponsor: **Sanwa Kagaku Kenkyusho Co., Ltd.**

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** miglitol

## Key facts

- **NCT ID:** NCT00213122
- **Lead sponsor:** Sanwa Kagaku Kenkyusho Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2006-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00213122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00213122, "Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00213122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*